Savara Inc Deferred Tax Assets, Operating Loss Carryforwards, Foreign
Savara Inc (SVRA) had Deferred Tax Assets, Operating Loss Carryforwards, Foreign of $177.10 million as of 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign · last filed 2026-03-13
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $177.10M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $137.70M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $96.00M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $81.80M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign as first filed |
|---|---|---|
| 2025-12-31 | $177.10M 10-K · filed 2026-03-13 | |
| 2024-12-31 | $137.70M 10-K · filed 2026-03-13 | |
| 2023-12-31 | $96.00M 10-K · filed 2025-03-27 | |
| 2022-12-31 | $81.80M 10-K · filed 2024-03-07 | |
| 2021-12-31 | $71.80M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $54.80M 10-K · filed 2022-03-30 | |
| 2019-12-31 | $40.30M 10-K · filed 2021-03-10 | |
| 2018-12-31 | $23.10M 10-K · filed 2020-03-12 | |
| 2017-12-31 | $1.80M 10-K · filed 2020-03-12 | $9.50M 10-K · filed 2018-03-14 |
| 2016-12-31 | $400.00K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |